Myriad Genetics (MYGN) 10-Q2014 Q1 Quarterly report

Filed: 12 Nov 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accurate, accurately, affiliate, alleging, Ambry, answer, antitrust, asserted, BARTTM, biological, biopsy, BRCA, calendar, California, Canada, celebrity, Central, Children, commenced, complaint, Counsyl, dermatopathologist, divested, Division, enable, endometrial, Endorecherche, external, Foundation, gastric, gene, GeneDx, Hospital, HSC, inAssociation, infringe, infringed, infringement, infringing, injunction, injunctive, Institute, instituted, introducing, led, lower, lung, motion, Munich, myPath, myPlan, myRisk, myRiskTM, negatively, Northern, Partnership, Pathology, pending, Pennsylvania, preliminary, produce, purport, purpose, Quest, relief, requested, rollout, Sherman, Sick, skin, suit, themyRiskTM, thought, tissue, University, Utah, vigorously, wane, Zurich

Removed: accuracy, agency, appeal, brought, category, cell, challenged, Circuit, claim, composition, cover, defendant, deficit, degree, disorder, employ, European, foreseeable, high, higher, improve, isolated, Italy, lawsuit, manage, municipal, mutual, office, OnDose, pursued, remand, remanded, Restated, ruled, ruling, screening, separate, sought, Southern, Spain, trade, understanding, unenforceable, vacated

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MYGN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: November 12, 2013		Date: November 12, 2013

By:	/s/ Peter D. Meldrum	By:	/s/ James S. Evans
	Peter D. Meldrum		James S. Evans
	President and Chief Executive Officer		Chief Financial Officer